A model of hypertension and proteinuria in cancer patients treated with the anti-angiogenic drug E7080

Hypertension and proteinuria are commonly observed side-effects for anti-angiogenic drugs targeting the VEGF pathway. In most cases, hypertension can be controlled by prescription of anti-hypertensive (AH) therapy, while proteinuria often requires dose reductions or dose delays. We aimed to construc...

Descripción completa

Detalles Bibliográficos
Autores principales: Keizer, Ron J., Gupta, Anubha, Mac Gillavry, Melvin R., Jansen, Mendel, Wanders, Jantien, Beijnen, Jos H., Schellens, Jan H. M., Karlsson, Mats O., Huitema, Alwin D. R.
Formato: Texto
Lenguaje:English
Publicado: Springer US 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921067/
https://www.ncbi.nlm.nih.gov/pubmed/20652729
http://dx.doi.org/10.1007/s10928-010-9164-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921067/
https://www.ncbi.nlm.nih.gov/pubmed/20652729
http://dx.doi.org/10.1007/s10928-010-9164-2

Ejemplares similares